@virtahealth and others could potentially fund and run such a trial yeah?
-
-
Wow, I do not agree with the conclusions here. All of the studies were at high risk of bias, heterogeneity was a big issue, half of the included patients were from a non-randomized trial, and there was no publication bias assessment...pic.twitter.com/gB3hSCx0oH
-
And this is their methods section???? This is not even close to enough informationpic.twitter.com/fw01hN4h5B
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.